Skip to main content
Premium Trial:

Request an Annual Quote

Steven Smith, Albrecht Frauendorf, Kenneth Noonan


Micromirror array startup NimbleGen Systems of Madison, Wis., has hired Steven Smith as vice president of bioinformatics and Albrecht Frauendorf as senior director of DNA array manufacturing.

Smith comes to NimbleGen from his own bioinformatics consulting firm, Genesmith Informatics. He also has worked as manager of R&D and senior software engineer at Genetics Computer Group, where he led development of the Wisconsin Sequence Analysis Package, and served as the director of computation at the Harvard Genome Library, where he led the effort to sequence the Mycoplasma capricolum genome. Smith received his B.S. in computer science from the University of Illinois School of Engineering.

Frauendorf previously worked in a number of capacities at DNA microarray startup Protogene, supervising microarray manufacturing and scale-up. Frauendorf completed postdoctoral work at Northwestern University and received his PhD in biological chemistry from the University of Frankfurt.


Orchid BioSciences of Princeton, NJ, has re-appointed Kenneth Noonan, a partner at LEK Consulting LLP in London, to its board of directors. Noonan, who earlier served on Orchid’s board, replaces Anne VanLent, who resigned last year. Prior to joining LEK, Noonan served as senior vice president of corporate development for Applera, crafting business deals for both Celera and Applied Biosystems. He has also worked as a vice president and head of the European pharmaceutical practice for Booz-Allen & Hamilton. He holds a PhD in biochemistry from Princeton University.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.